Литература

Lind I. Antimicrobial resistance in N.gonorrhoeae. WHO Collaborating Centre for Reference and Research in Gonococci, Denmark. // Clin. Infect. Dis. 1997. 24 Suppl 1. P. 93–97.
Gonococcal infections. // Sexually Transmitted Diseases Treatment Guidelines 2002. P. 36–37.
Mogabgab WJ, Lutz FB. Randomized study of cefotaxime versus ceftriaxone for uncomplicated gonorrhea. // South Med J. 1994 Apr; 87(4): 461–4.
Hook EW 3 rd, Jones RB, Martin DH, Bolan GA, Mroczkowski TF, Neumann TM, Haag JJ, Echols R. Comparison of ciprofloxacin and ceftriaxone as single-dose therapy for uncomplicated gonorrhea in women.// Antimicrob Agents Chemother. 1993 Aug; 37(8): 1670–3.
Rompalo AM, Colletta L, Caine VA, Linnemeier P, Neumann T, Hook EW 3 rd, Jones RB. Efficacy of 250 mg trospectomycin sulfate i.m. vs. 250 mg ceftriaxone i.m. for treatment of uncomplicated gonorrhea.// Sex Transm Dis. 1994 Jul-Aug; 21(4): 213–6.
Brocklehurst P. Antibiotics for gonorrhoea in pregnancy.// Cochrane Database Syst Rev. 2002; (2): CD000098. Review.
McCormack WM, Mogabgab WJ, Jones RB, Hook EW 3 rd, Wendel GD Jr, Handsfield HH. Multicenter, comparative study of cefotaxime and ceftriaxone for treatment of uncomplicated gonorrhea.// Sex Transm Dis. 1993 Sep-Oct; 20(5): 269–73.

Для продолжения работы требуется Регистрация

Предыдущая страница

Следующая страница